In support of this possibility, the repRNA vaccine induced robust humoral immune responses in animals with low to moderate peripheral CD4+ T-cell counts of 400-750 cells/μL of blood, but further evaluation of COVID-19 vaccines in a setting of severe CD4 depletion (< 250 cells/μL) is needed. This evidence concerns the gene CD4 and COVID-19.